Integrated Quality Assurance: A systems-level approach to resolving your biggest QA headaches
Pharmaceutical QA departments exist at a critical nexus of different functions in the drug production supply chain, ultimately acting as the gatekeepers for the final release-to-market process.
Delays in the Quality pipeline can have lasting impacts on both manufacturing and distribution timelines, which can present significant risks to a company’s commercial commitments.
Despite their important role, QA teams are often sidelined in digital transformation and tech transfer strategy, with priority given to departments that traditionally have a more direct interface with digital technologies.
In this white paper, we consider some of the most common pain points that lead to delays in the QA process and present a range of solutions grounded in Industry 4.0 principles.
Download our report to find out how embracing digital transformation and systems-level thinking can help to reduce:
- Deviation reporting bottlenecks
- Low right first time rates
- Upstream delays
- Workload volatility
- Capacity issues
- Operational variability
- Communication barriers
- Batch prioritization conflicts
- Information silos